DrugCite
Search

CARBOCISTEINE

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Carbocisteine Adverse Events Reported to the FDA Over Time

How are Carbocisteine adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Carbocisteine, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Carbocisteine is flagged as the suspect drug causing the adverse event.

Most Common Carbocisteine Adverse Events Reported to the FDA

What are the most common Carbocisteine adverse events reported to the FDA?

Pyrexia
13 (2.2%)
Infective Exacerbation Of Chronic O...
11 (1.86%)
Renal Failure
11 (1.86%)
Chronic Obstructive Pulmonary Disea...
10 (1.69%)
Urinary Retention
10 (1.69%)
Drug Eruption
9 (1.53%)
Hepatitis Acute
9 (1.53%)
Tubulointerstitial Nephritis
9 (1.53%)
Liver Disorder
8 (1.36%)
Malaise
8 (1.36%)
Nasopharyngitis
8 (1.36%)
Show More Show More
Rhabdomyolysis
8 (1.36%)
Dialysis
7 (1.19%)
Leukocytoclastic Vasculitis
7 (1.19%)
Lymphocyte Stimulation Test Positiv...
7 (1.19%)
Pneumonia
7 (1.19%)
Alanine Aminotransferase Increased
6 (1.02%)
Aspartate Aminotransferase Increase...
6 (1.02%)
Asthenia
6 (1.02%)
Convulsion
6 (1.02%)
Pruritus
6 (1.02%)
Toxic Epidermal Necrolysis
6 (1.02%)
Vomiting
6 (1.02%)
Allergic Granulomatous Angiitis
5 (.85%)
Apnoeic Attack
5 (.85%)
Dyspnoea
5 (.85%)
Febrile Neutropenia
5 (.85%)
Hepatic Function Abnormal
5 (.85%)
Shock
5 (.85%)
Acute Generalised Exanthematous Pus...
4 (.68%)
Anorexia
4 (.68%)
Asthma
4 (.68%)
Condition Aggravated
4 (.68%)
Cyanosis
4 (.68%)
Depression
4 (.68%)
Face Oedema
4 (.68%)
Gamma-glutamyltransferase Increased
4 (.68%)
Hypomagnesaemia
4 (.68%)
Infection
4 (.68%)
Oedema Peripheral
4 (.68%)
Pigmentation Disorder
4 (.68%)
Rash
4 (.68%)
Reversible Posterior Leukoencephalo...
4 (.68%)
Skin Exfoliation
4 (.68%)
Abdominal Pain Upper
3 (.51%)
Acidosis
3 (.51%)
Acute Respiratory Distress Syndrome
3 (.51%)
Anaphylactic Shock
3 (.51%)
Bacterial Infection
3 (.51%)
Beta Haemolytic Streptococcal Infec...
3 (.51%)
Blood Lactate Dehydrogenase Increas...
3 (.51%)
Cardiac Failure
3 (.51%)
Cardio-respiratory Arrest
3 (.51%)
Colitis
3 (.51%)
Diarrhoea
3 (.51%)
Drug Hypersensitivity
3 (.51%)
Epstein-barr Virus Antibody Positiv...
3 (.51%)
Erythema
3 (.51%)
Erythema Multiforme
3 (.51%)
Flushing
3 (.51%)
Gastric Cancer
3 (.51%)
Generalised Erythema
3 (.51%)
Hyperglobulinaemia
3 (.51%)
Hypoxia
3 (.51%)
Measles
3 (.51%)
Myelodysplastic Syndrome
3 (.51%)
Pharyngeal Erythema
3 (.51%)
Purpura
3 (.51%)
Pyelonephritis
3 (.51%)
Rash Pustular
3 (.51%)
Renal Failure Acute
3 (.51%)
Rhinorrhoea
3 (.51%)
Toxic Skin Eruption
3 (.51%)
Upper Respiratory Tract Infection
3 (.51%)
Vaginal Discharge
3 (.51%)
Vasculitis
3 (.51%)
Abasia
2 (.34%)
Acute Respiratory Failure
2 (.34%)
Alpha 2 Globulin Increased
2 (.34%)
Arthralgia
2 (.34%)
Back Pain
2 (.34%)
Blood Alkaline Phosphatase Increase...
2 (.34%)
Blood Bilirubin Increased
2 (.34%)
C-reactive Protein Increased
2 (.34%)
Cerebral Haemorrhage
2 (.34%)
Cerebral Infarction
2 (.34%)
Cough
2 (.34%)
Disseminated Cryptococcosis
2 (.34%)
Drug Ineffective
2 (.34%)
Drug Interaction
2 (.34%)
Drug Level Above Therapeutic
2 (.34%)
Drug Rash With Eosinophilia And Sys...
2 (.34%)
Eosinophilia
2 (.34%)
Fatigue
2 (.34%)
Feeling Hot
2 (.34%)
Gastric Ulcer
2 (.34%)
Haematuria
2 (.34%)
Haemodialysis
2 (.34%)
Hypotension
2 (.34%)
Inflammation
2 (.34%)
Insomnia
2 (.34%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Carbocisteine, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Carbocisteine is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Carbocisteine

What are the most common Carbocisteine adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Carbocisteine, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Carbocisteine is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Carbocisteine According to Those Reporting Adverse Events

Why are people taking Carbocisteine, according to those reporting adverse events to the FDA?

Drug Use For Unknown Indication
123
Product Used For Unknown Indication
51
Bronchitis
43
Cough
31
Productive Cough
30
Upper Respiratory Tract Inflammatio...
27
Show More Show More
Nasopharyngitis
26
Chronic Obstructive Pulmonary Disea...
18
Pharyngitis
12
Asthma
11
Emphysema
9
Bronchitis Chronic
8
Pneumonia
8
Pyrexia
6
Sinusitis
6
Prophylaxis
6
Ill-defined Disorder
6
Primary Ciliary Dyskinesia
6
Eustachian Tube Stenosis
5
Diffuse Panbronchiolitis
5
Herpes Simplex
4
Bronchitis Acute
4
Bronchiolitis
4
Multiple System Atrophy
4
Tinnitus
3
Otitis Media
3
Infection Prophylaxis
3
Antiallergic Therapy
2
Glycogen Storage Disease Type Ii
2
Bronchitis Viral
2
Increased Viscosity Of Bronchial Se...
2
Antiviral Prophylaxis
2
Breast Cancer Metastatic
2
Otitis Externa
2
Upper Respiratory Tract Infection
2
Mucopolysaccharidosis Ii
2
Pneumonia Aspiration
2
Acute Myeloid Leukaemia
2
Sputum Retention
2
Suicide Attempt
1
Rhinorrhoea
1
Myalgia
1
Secretion Discharge
1
Purulent Discharge
1
Nasal Septum Deviation
1
Pharyngolaryngeal Pain
1
Pseudomonal Sepsis
1
Pneumoconiosis
1
Lung Neoplasm Malignant
1
Drug Exposure During Pregnancy
1
Influenza
1

Carbocisteine Case Reports

What Carbocisteine safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Carbocisteine. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Carbocisteine.